Provided by Tiger Fintech (Singapore) Pte. Ltd.

Verrica Pharmaceuticals Inc.

0.6483
+0.04737.87%
Volume:1.04M
Turnover:664.04K
Market Cap:59.96M
PE:-0.63
High:0.6590
Open:0.6200
Low:0.5811
Close:0.6010
Loading ...

BRIEF-Verrica Pharmaceuticals - To Receive $8 Million Milestone Payment In July 2025

Reuters
·
01 Jul

Verrica Pharmaceuticals Announces Launch of Global Phase 3 Trial for YCANTH® to Treat Common Warts, Anticipates Dosing First Patient in Late 2025

Reuters
·
01 Jul

Verrica Pharmaceuticals Announces Amendment to Collaboration and License Agreement With Torii Pharmaceutical to Launch Global Pivotal Phase 3 Clinical Trial to Study Ycanth® for the Treatment of Common Warts

THOMSON REUTERS
·
01 Jul

Verrica Pharmaceuticals Inc - Torii to Fund First $40 Mln of Global Study Costs

THOMSON REUTERS
·
01 Jul

Verrica Pharmaceuticals Inc - to Receive $8 Mln Milestone Payment in July 2025

THOMSON REUTERS
·
01 Jul

Verrica Pharmaceuticals Announces Sixth Amendment to Credit Agreement with Lenders

Reuters
·
13 Jun

Verrica Pharmaceuticals Inc. Conducted Annual Stockholders Meeting

Reuters
·
06 Jun

Verrica Pharmaceuticals to Present at the Jefferies Global Healthcare Conference in New York City

Reuters
·
28 May

Verrica Pharmaceuticals Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
15 May

Verrica Pharmaceuticals Q1 Adj. EPS $(0.08) Beats $(0.10) Estimate, Sales $3.44M Beat $2.51M Estimate

Benzinga
·
14 May

Verrica Pharmaceuticals Reports Reduced Net Loss of $9.7M and EPS of $0.10 for Q1 2025, Improvement from $20.3M Loss and $0.44 EPS in Q1 2024

Reuters
·
14 May

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
13 May

Verrica Pharmaceuticals Inc expected to post a loss of 10 cents a share - Earnings Preview

Reuters
·
09 May

Verrica Pharmaceuticals to Report First Quarter 2025 Financial Results and Provide a Corporate Update on May 13, 2025

THOMSON REUTERS
·
07 May

Verrica Pharmaceuticals to Participate in the Citizens Life Sciences Conference in New York

GlobeNewswire
·
30 Apr

Analysts Offer Insights on Healthcare Companies: Roche Holding AG (OtherRHHVF) and Verrica Pharmaceuticals (VRCA)

TIPRANKS
·
07 Apr

BRIEF-Verrica Pharmaceuticals Reports Strong Demand-Led Growth In Ycanth® In Q1 2025

Reuters
·
07 Apr

Verrica Pharmaceuticals Reports Strong Demand-Led Growth in Ycanth® Dispensed Applicator Units in First Quarter 2025

THOMSON REUTERS
·
07 Apr

Verrica Pharmaceuticals Reports Strong Demand-Led Growth in YCANTH® Dispensed Applicator Units in First Quarter 2025

GlobeNewswire
·
07 Apr

RBC Capital Sticks to Their Hold Rating for Verrica Pharmaceuticals (VRCA)

TIPRANKS
·
05 Apr